Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Pets Might Be Adding To Antibiotic Resistance

TUESDAY, May 20, 2025 Antibiotic resistance is a growing threat to human health, as germs like E. coli and staph gain the power to overcome even the most powerf

Brain Wave Decoder Figures Out How To Cause Movement In Spinal Cord Injuries

MONDAY, May 20, 2025 A brain wave decoder shows promise in using electrical stimulation to the spine to cue leg movement, researchers say.The decoder could one

Recovering From A Heart Attack? Here's What You Shouldn't Do

TUESDAY, May 20, 2025 Lounging around too much after a heart attack can set you up for another one, a new study says.Within a year of being treated for heart at

Heart Failure Patients Increase Their Odds Of Death By Skipping Yearly Doctor Visit

TUESDAY, May 20, 2025 Two out of 5 people with heart failure are more likely to die because they aren t regularly seeing a cardiologist, a new study says.The 3

Infant with Carbamoyl Phosphate Synthetase 1 (CPS1) Deficiency First to Successfully Receive Personalized Gene Therapy Treatment

A research team supported by the National Institutes of Health (NIH) has developed and safely delivered a personalized gene editing therapy to treat an infant w

IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Tokyo and Basking Ridge, NJ May 19, 2025 The first patient has been dosed in the IDeateEsophageal01 phase 3 trial evaluating the efficacy and safety of investig

Apnimed Announces Positive Topline Results in the First Landmark Phase 3 Clinical Trial of AD109, an Investigational Once-Daily Oral Pill for Obstructive Sleep Apnea

CAMBRIDGE, Mass., May 19, 2025 Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that addre

Global Phase III Trials Demonstrate That Nerandomilast Slowed Lung Function Decline in IPF and PPF, with Similar Discontinuation Rates to Placebo

Ingelheim, Germany, May 19, 2025 - Boehringer Ingelheim announced today detailed findings from the Phase III FIBRONEER -IPF and FIBRONEER -ILD trials. These stu

Nicotine Pouch Use in Teens Linked to Lower Risk for Continued Vaping

Nicotine pouch use in adolescence is associated with a lower likelihood of continued vaping, according to a study published online May 19 in Pediatrics.Alyssa F

Calorie Restrictions, Low-Fat Diets May Reduce Depressive Symptoms

Among adults with elevated cardiometabolic risk, calorie restrictions and low-fat diets may reduce depressive symptoms, according to a review published online M

Popular Keywords